SET: Immunoassay Blood Test For Amyloid Pathology Assessment
FDA product code SET: Immunoassay Blood Test For Amyloid Pathology Assessment. View classification details, related manufacturers, 510(k) clearances, and recall records.
Immunoassay Blood Test For Amyloid Pathology Assessment
Device class
2
Regulation number
866.5840
Medical specialty
Immunology
Review panel
IM
FDA definition
An Immunoassay blood test for amyloid pathology assessment is an in vitro diagnostic test used to identify patients with amyloid pathology associated with Alzheimers Disease who have signs and symptoms of cognitive decline. The results of the test are to be interpreted in conjunction with other patient clinical information.
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope
4 clearance records and 7 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from May 16, 2025 to Aug 19, 2026.
All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.